Did you know?
The groundbreaking study referenced in February’s issue of GEN: Genetic Engineering & Biotechnology News used our Human PAI-1 Total Antigen Assay ELISA Kit!
Human PAI-1 total antigen assay ELISA kit
Plasminogen activator inhibitor type 1 (PAI-1) is involved in the regulation of the blood fibrinolytic system. Increased plasma levels of PAI-1 are implicated in the impairment of fibrinolytic function and may be associated with thrombotic diseases. Levels of PAI-1 increase with age and are elevated in conditions such as normal pregnancy and sepsis.
Questions? Contact Us!
Additional PAI-1 Products
from Molecular Innovations:
About Molecular Innovations
Molecular Innovations, founded in 1990, is a primary manufacturer of research antibodies, proteins and ELISA kits. We specialize in coagulation and thrombolysis reagents including PAI-1, tPA, urokinase, clotting factors, vitronectin, fibrinogen, fibronectin, clotting factors, prorenin/renin, albumin, and immunoglobulins. Our customers all over the world include pharmaceutical and biotechnology companies as well as major research institutions. We offer custom projects and bulk quotes. All products are manufactured under stringent quality control standards at our new state of the art facility in Novi, MI, USA.
New York Times article:
Science Advances article:
“Plasma samples preserved in citrate were assayed for human PAI-1 total antigen with the Molecular Innovations PAI-1 ELISA…The intra-assay CV was 6.15%, and the inter-assay CV was 5.98%.”